Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR

Affiliation auteurs!!!! Error affiliation !!!!
TitreOverall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR
Type de publicationJournal Article
Year of Publication2018
AuteursReix B., Bernhard J.-C, Patard J.-J, Bigot P., Villers A., Suer E., Vuong N.S, Verhoest G., Alimi Q., Beauval J.-B, Benoit T., Nouhaud F.-X, Lenormand C., Hamidi N., Cai J., Eto M., Larre S., A. Bakhri E, Ploussard G., Hung A., Koutlidis N., Schneider A., Carrouget J., Droupy S., Marchal S., Doerfler A., Seddik S., Matsugasumi T., Orsoni X., Descazeaud A., Pfister C., Bensalah K., Soulie M., Gill I., Flamand V., CCAFU KCanc Grp
JournalPROGRES EN UROLOGIE
Volume28
Pagination146-155
Date PublishedMAR
Type of ArticleArticle
ISSN1166-7087
Mots-clésoncology, outcomes, partial nephrectomy, Renal Cancer, Sparing surgery
Résumé

{Background. - Partial nephrectomy (PN) is recommended as first-line treatment for cT1 stage kidney tumors because of a better renal function and probably a better overall survival than radical nephrectomy (RN). For larger tumors, PN has a controversial position due to lack of evidence showing good cancer control. The aim of this study was to compare the results of PN and RN in cT2a stage on overall survival and oncological results. Method. - A retrospective international multicenter study was conducted in the frame of the French kidney cancer research network (UroCCR). We considered all patients aged >= 18 years who underwent surgical treatment for localized renal cell carcinoma (RCC) stage cT2a (7.1-10 cm) between 2000 and 2014. Cox and Fine-Gray models were performed to analyze overall survival (OS), cancer specific survival (CSS) and cancer-free survival (CFS). Comparison between PN and RN was realized after an adjustment by propensity score considering predefined confounding factors: age, sex, tumor size, pT stage of the TNM classification, histological type, ISUP grade, ASA score. Results. - A total of 267 patients were included. OS at 3 and 5 years was 93.6% and 78.7% after PN and 88.0% and 76.2% after RN, respectively. CSS at 3 and 5 years was 95.4% and 80.2% after PN and 91.0% and 85.0% after RN. No significant difference between groups was found after propensity score adjustment for OS (HR 0.87, 95% CI: 0.37-2.05

DOI10.1016/j.purol.2017.12.004